Physician profile
John Robert Gusz
NPI 1346294683
$497.81
in general payments reported to CMS, 2019-2025
10 companies · $135 in 2025
The $135 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $111 · 2020: $14.10 · 2021: $43.81 · 2022: $14.54 · 2023: $147 · 2024: $31.92 · 2025: $135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $314.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $314.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $119.31 | 2025 | Spyglass Discover |
| Ekos Corporation | $99.10 | 2019 | |
| Becton, Dickinson and Company | $85.11 | 2023 | Phasix Mesh |
| Qol Medical, LLC | $59.88 | 2023-2024 | Sucraid, Sucraid |
| Braintree Laboratories, INC. | $39.24 | 2020-2021 | |
| Abbvie INC. | $30.91 | 2019-2021 | |
| Ethicon US, LLC | $19.29 | 2023 | Echelon; Endopath |
| Celltrion USA INC. | $15.92 | 2025 | Vegzelma |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.54 | 2022 | |
| Conmed Corporation | $14.51 | 2024 | Airseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Gusz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.